| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 110 |
| 1 | DOXORUBICIN | 102 |
| 2 | SOFOSBUVIR | 98 |
| 3 | RIBAVIRIN | 96 |
| 4 | PREDNISONE | 94 |
| 5 | VEDOLIZUMAB | 40 |
| 6 | CYCLOPHOSPHAMIDE | 37 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 37 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 37 |
| 9 | MYCOPHENOLATE MOFETIL | 33 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOFOSBUVIR | 98 | 0.0050 |
| 1 | STREPTOZOCIN | 1 | 0.0043 |
| 2 | CLOFARABINE | 5 | 0.0022 |
| 3 | DASATINIB | 17 | 0.0018 |
| 4 | ASCIMINIB | 6 | 0.0017 |
| 5 | RIBAVIRIN | 96 | 0.0015 |
| 6 | GILTERITINIB | 5 | 0.0012 |
| 7 | INFLIXIMAB-DYYB | 4 | 0.0012 |
| 8 | DOXORUBICIN | 102 | 0.0011 |
| 9 | INOTUZUMAB OZOGAMICIN | 3 | 0.0010 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 98 | 0.0019 |
| 1 | Nucleoside Analog Antiviral [EPC] | 96 | 0.0011 |
| 2 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 3 | CD22-directed Immunoconjugate [EPC] | 3 | 0.0010 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 5 | 0.0009 |
| 5 | Integrin Receptor Antagonist [EPC] | 40 | 0.0005 |
| 6 | Bile Acid Sequestrant [EPC] | 5 | 0.0004 |
| 7 | Catechol-O-Methyltransferase Inhibitor [EPC] | 2 | 0.0004 |
| 8 | Erythroid Maturation Agent [EPC] | 1 | 0.0004 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 113 | 0.0004 |